Molnupiravir per la malattia COVID-19
Lagevrio
Revisione paritaria di Sid DajaniUltimo aggiornamento di Michael Stewart, MRPharmSUltimo aggiornamento 15 Dic 2024
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Molnupiravir is given to adults aged over 18 years when they have tested positive for COVID-19 and have at least one risk factor for developing severe illness.
Treatment should be started as soon as possible after diagnosis and within the first five days of symptoms.
The most common side-effects are feeling sick (nausea) and diarrhoea.
Scelte video per Medicinali per il trattamento delle infezioniVideo library
About molnupiravir
Tipo di medicinale | Antiviral agent |
Utilizzato per | Treatment of mild to moderate COVID-19 disease in adults |
Chiamato anche | Lagevrio® |
Disponibile come | Capsule |
Molnupiravir is an antiviral agent that works by combining with viral RNA to stop the virus particles from replicating. If a virus can't replicate it won't be able to infect other cells in the body and the infection won't spread as quickly. Molnupiravir can reduce the severity of viral infections such as COVID-19.
Molnupiravir is used for adults who have tested positive for COVID-19 and have at least one risk factor for severe disease. Taking molnupiravir as soon as possible once COVID-19 symptoms have started can lower your risk of being severely ill or requiring hospitalisation.
People at high risk of severe COVID-19 disease include those with medical conditions such as long-term heart, lung, liver, kidney or nerve problems, people with diabetes and people with weakened immune systems.
Before taking molnupiravir capsules
Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start taking molnupiravir it is important that your doctor knows:
Se sei incinta, stai cercando di avere un bambino o stai allattando.
Se hai mai avuto una reazione allergica a un medicinale.
Se stai assumendo altri medicinali. Questo include qualsiasi medicinale che stai assumendo e che è disponibile per l'acquisto senza prescrizione medica, così come i medicinali a base di erbe e complementari.
How to take molnupiravir capsules
Before you start this treatment, read the manufacturer's printed information leaflet from inside your pack. The manufacturer's leaflet will give you more information about molnupiravir and a full list of side-effects which you may experience from taking it.
The usual dose of molnupiravir is four capsules (800 mg) taken every twelve hours for five days. Make sure you complete the course even if you are feeling better.
Swallow the capsules whole with a drink of water. Do not open, crush or chew the capsules.
It is not important whether you take molnupiravir capsules before or after food.
If you forget to take a dose, take it as soon as you remember unless it is nearly time for your next dose. In which case, leave out the forgotten dose and take your next dose when it is due. Do not take two doses together to make up for a missed dose.
Ottenere il massimo dal tuo trattamento
Treatment with molnupiravir should be started within the first five days of COVID-19 symptoms or as soon as possible after a positive COVID-19 test result.
Make sure you complete the full course of treatment even if you start to feel better or do not feel unwell.
Help your body fight the infection by drinking plenty of water, eating sensibly and getting plenty of rest.
The best way to protect yourself from COVID-19 is through vaccination. Ensure your vaccinations are up to date in line with national guidance.
Can molnupiravir cause problems?
Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains some of the most common ones associated with molnupiravir. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.
Common molnupiravir side-effects (affecting fewer than 1 in 10 people) | Cosa posso fare se sperimento questo? |
Diarrea | Bevi molta acqua per reintegrare i liquidi persi |
Sensazione di nausea | Stick to simple foods. Try taking your doses with something to eat if you are not already doing so |
Vertigini | Do not drive and do not use tools or machines if affected |
Importante: In rare cases this medicine may cause a serious allergic reaction. Seek urgent medical attention if you develop a red, itchy skin rash and any difficulties with your breathing, including swelling of the face, lips or tongue. Taking an antihistamine may help slow the reaction whilst you are waiting for treatment.
Se si verificano altri sintomi che ritieni possano essere dovuti a questo medicinale, parla con il tuo medico o farmacista.
How to store molnupiravir capsules
Tenere tutti i medicinali fuori dalla portata e dalla vista dei bambini.
Conservare in un luogo fresco e asciutto, lontano da fonti di calore e luce diretta.
Informazioni importanti su tutti i medicinali
Informazioni importanti su tutti i medicinali
Non assumere mai più della dose prescritta. Se sospetti che tu o qualcun altro possa aver assunto un sovradosaggio di questo medicinale, recati al pronto soccorso del tuo ospedale locale. Porta con te il contenitore, anche se è vuoto.
Questo medicinale è per te. Non darlo mai ad altre persone, anche se la loro condizione sembra essere la stessa della tua.
Non conservare medicinali scaduti o indesiderati. Portali alla tua farmacia locale che li smaltirà per te.
Se hai domande su questo medicinale, chiedi al tuo farmacista.
Segnala effetti collaterali di un medicinale o vaccino
Se si verificano effetti collaterali, è possibile segnalarli online tramite il Sito web Yellow Card.
Domande frequenti
What is the age range for taking molnupiravir?
Molnupiravir is specifically used for adults aged 18 and over who have tested positive for COVID-19.
Why is it important to complete the full five-day course of molnupiravir, even if I feel better?
Completing the full course of treatment helps ensure the medication effectively stops the virus from replicating, which can reduce the severity of the infection and lower your risk of being severely ill or requiring hospitalisation. It's crucial to finish the entire course to give the medicine the best chance to work, even if your symptoms improve.
What should I do if I accidentally take two doses of molnupiravir at once?
You should never take two doses together to make up for a missed dose. If you suspect you or someone else might have taken an overdose of this medicine, you should go to the accident and emergency department of your local hospital immediately. Remember to take the medicine container with you, even if it is empty.
What are the common symptoms of a severe allergic reaction to molnupiravir?
Signs of a serious allergic reaction include a red, itchy skin rash, difficulties with your breathing, and swelling of the face, lips, or tongue. If you experience any of these symptoms, you should seek urgent medical attention.
Does molnupiravir interact with any other medications I might be taking?
Before starting molnupiravir, it's important to inform your doctor about all other medicines you are currently taking. This includes any over-the-counter medicines, as well as herbal and complementary medicines. Your doctor needs this information to ensure molnupiravir is suitable for you and to check for potential interactions.
Ulteriori letture e riferimenti
- Manufacturer's PIL, Lagevrio® 200 mg hard capsules; Merck Sharp and Dohme (UK) Ltd, The electronic Medicines Compendium. Dated July 2024.
- Medicinali Completi BNF 89ª Edizione; Associazione Medica Britannica e Società Farmaceutica Reale di Gran Bretagna, Londra.
Informazioni sul recensore

Sid Dajani
Sultan Dajani si è laureato alla London School of Pharmacy nel 1994 ed è diventato il più giovane membro eletto del consiglio della Royal Pharmaceutical Society dalla sua fondazione nel 1842.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.
Più nella medicina per il trattamento delle infezioni
- Acido azelaico
- Cefaclor per infezione
- Cloramfenicolo per infezioni oculari
- Compresse di clorochina e medicina liquida
- Preparazioni oculari di ciprofloxacina
- Colistimetato sodico per infezione
- Compresse di Efavirenz per l'HIV
- Fenticonazolo per la candidosi vaginale
- Gel oculare di ganciclovir
- Isoniazide per la tubercolosi
- Crema al ketoconazolo
- Miconazolo per candidosi vaginale
- Crema di permetrina
- Proguanil per la prevenzione della malaria
- Vaccino contro il rotavirus
- Fusidato di sodio per infezioni
- Stavudina per l'HIV
- Compresse di sulfadiazina
- Tenofovir per l'infezione da epatite B
- Compresse di terbinafina


